Company news

Polaris Group news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Lombard backs Polaris Autoliners fleet expansion with 33.2 million refinancing deal

September 28, 2026

Polaris Group Announced the Acquisition of Genovior Biotech, Initiating Dual-Engine Growth

December 21, 2023

Polaris Group Initiates Phase 3 Trial: First Patient Successfully Dosed with ADI-PEG 20/Placebo plus Gemcitabine and Docetaxel for Difficult-to-Treat Leiomyosarcoma (LMS)

December 4, 2023

Polaris Group Announces First Patient Successfully Dosed with ADI-PEG 20/Placebo in Phase 2a Non-Alcoholic Steatohepatitis (NASH) Study

November 29, 2023

Polaris Group Initiates Rolling Submission of Biologic License Application (BLA) for ADI-PEG 20 with U.S. FDA to Treat Malignant Pleural Mesothelioma

November 16, 2023

The Board resolved the consolidated financial statements for the second quarter of 2022

August 16, 2022

Board of Directors resolved to issue employee stock options certificates

August 16, 2022

Announcement for appointing the Corporate Governance Officer

August 16, 2022

Polaris Group: (Announcement of correction) Polaris Group will attend 2022 Cathay Biopharmaceutical Corporate DayHosted by Cathay Securities.

August 15, 2022

Announcement of the progress of the company's committed items at the time when the stock was listed on TWSE.

July 8, 2022

Decks